Secretion of IL-1β from imatinib-resistant chronic myeloid leukemia cells contributes to BCR-ABL mutation-independent imatinib resistance

FEBS Letters
Cho-Rong LeeSung-Gyoo Park

Abstract

Some cases of chronic myelogenous leukemia are resistant to tyrosine kinase inhibitors (TKIs) independently of mutation in BCR-ABL, but the detailed mechanism underlying this resistance has not yet been elucidated. In this study, we generated a TKI-resistant CML cell line, K562R, that lacks a mutation in BCR-ABL. Interleukin-1β (IL-1β) was more highly expressed in K562R than in the parental cell line K562S, and higher levels of IL-1β contributed to the imatinib resistance of K562R. In addition, IL-1β secreted from K562R cells affected stromal cell production of CXCL11, which in turn promoted migration of K562R cells into the stroma. Thus, elevated IL-1β production from TKI-resistant K562R cells may contribute to TKI resistance by increasing cell viability and promoting cell migration.

References

Oct 15, 1976·International Journal of Cancer. Journal International Du Cancer·E KleinF Vánky
Jul 1, 1972·The Journal of Experimental Medicine·I GeryB H Waksman
Feb 26, 1998·Leukemia & Lymphoma·S RafiiM A Moore
Jul 15, 1999·The New England Journal of Medicine·S FaderlH M Kantarjian
Nov 17, 2001·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·U F HartwigC Peschel
Feb 22, 2002·Journal of Cellular Physiology·Yang Cao, Stephen M Prescott
May 8, 2002·American Journal of Hematology·Craig LitwinAly Karsan
Sep 11, 2002·Cytokine & Growth Factor Reviews·William P Arend
Feb 25, 2003·Proceedings of the National Academy of Sciences of the United States of America·Elena VoronovRon N Apte
May 21, 2003·Annals of Internal Medicine·Razelle KurzrockMoshe Talpaz
Jun 5, 2003·International Journal of Colorectal Disease·Milind RaoMarc C Winslet
Oct 10, 2003·The New England Journal of Medicine·Tim P HughesUNKNOWN International Randomised Study of Interferon versus STI571 (IRIS) Study Group
Jan 7, 2004·Nature Reviews. Molecular Cell Biology·Oliver Hantschel, Giulio Superti-Furga
Mar 17, 2004·Clinical Breast Cancer·Carsten DenkertSteffen Hauptmann
May 3, 2006·Proceedings of the National Academy of Sciences of the United States of America·Hans-Guido WendelScott W Lowe
Jun 16, 2007·The Journal of Pharmacology and Experimental Therapeutics·Sang Min LeeSun Hee Kim
Aug 15, 2008·Cytokine·Giovanni GermanoAlberto Mantovani
Nov 4, 2008·Leukemia Research·Yanina AssefBasilio A Kotsias
Mar 27, 2010·International Journal of Cell Biology·Cyril SobolewskiMarc Diederich
Sep 2, 2010·Proceedings of the National Academy of Sciences of the United States of America·Marcus JäråsThoas Fioretos
Sep 20, 2012·Cytokine & Growth Factor Reviews·Anup Kumar SinghDipak Datta

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.